Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cardiol Therapeutics Inc.

    NASDAQ: CRDL · Real-Time Price · USD
    1.42
    -0.04 (-2.74%)
    At close: Jun 16, 2025, 3:59 PM
    1.45
    2.11%
    Pre-market: Jun 17, 2025, 08:21 AM EDT

    Cardiol Therapeutics Statistics

    Share Statistics

    Cardiol Therapeutics has 82.65M shares outstanding. The number of shares has increased by 18.27% in one year.

    Shares Outstanding

    n/a
    		 82.65M

    Shares Change (YoY)

    n/a
    		 18.27%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 10.88%

    Shares Floating

    n/a
    		 78.7M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,626

    FTD / Avg. Volume

    n/a
    		 2.85%

    Short Selling Information

    The latest short interest is 1.99M, so 2.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.99M

    Short % of Shares Out

    n/a
    		 2.4%

    Short % of Float

    n/a
    		 2.5%

    Short Ratio (days to cover)

    n/a
    		 11.21

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -3.04

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cardiol Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 4.52

    Quick Ratio

    n/a
    		 4.52

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,562,682.83

    Employee Count

    n/a
    		 18

    Asset Turnover

    n/a
    		 n/a

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -35.45% in the last 52 weeks. The beta is 0.76, so Cardiol Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.76

    52-Week Price Change

    n/a
    		 -35.45%

    50-Day Moving Average

    n/a
    		 1.14

    200-Day Moving Average

    n/a
    		 1.45

    Relative Strength Index (RSI)

    n/a
    		 64.1

    Average Volume (20 Days)

    n/a
    		 197,457

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -248.35K

    Operating Income

    n/a
    		 -29.79M

    Net Income

    n/a
    		 -28.13M

    EBITDA

    n/a
    		 -29.59M

    EBIT

    n/a
    		 -29.79M

    Earnings Per Share (EPS)

    n/a
    		 -0.44
    Full Income Statement

    Balance Sheet

    The company has 30.58M in cash and 158.53K in debt, giving a net cash position of 30.42M.

    Cash & Cash Equivalents

    n/a
    		 30.58M

    Total Debt

    n/a
    		 158.53K

    Net Cash

    n/a
    		 30.42M

    Retained Earnings

    n/a
    		 -179.25M

    Total Assets

    n/a
    		 31.86M

    Working Capital

    n/a
    		 24.66M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -25.06M and capital expenditures -21.29K, giving a free cash flow of -25.08M.

    Operating Cash Flow

    n/a
    		 -25.06M

    Capital Expenditures

    n/a
    		 -21.29K

    Free Cash Flow

    n/a
    		 -25.08M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CRDL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CRDL is $9.5, which is 569% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9.5

    Price Target Difference

    n/a
    		 569%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2.22

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist